- Posted by John on February 17, 2017
Quick link: Register here!
Monday, March 13, 2017 from 6:00 PM - 9:30 PM
Near Kings Cross, London
Free Pizza & Drinks!
After a great turnout at our last #FuturePub in London in September, and given that lots of people are in town for the London Bookfair in March, we're hosting our tenth (!) #FuturePub as a pre-LBF event on March 13th!
- Posted by Mary Anne on January 13, 2017
Cambridge, UK – Friday, January 13, 2017: eLife is integrating new authoring tools into its submission system to give authors more choice about how they submit their work.
eLife, the non-profit initiative inspired by research funders and led by scientists, aims to help scientists accelerate discovery by operating a platform for research communication that encourages and recognises the most responsible behaviours in science. eLife is now working with Overleaf, Manuscripts.app, PubRef and Authorea, to allow authors to write and submit research to the journal as quickly and easily as possible.
- Posted by Mary Anne on November 30, 2016
London, UK and Boston, USA – November 30th, 2016: Three journals to provide authors with Overleaf’s cloud-based writing and collaborative features and streamlined submission process
- Overleaf, an innovative provider of scientific writing and publishing tools, today announced a partnership with Cambridge University Press (CUP) - the publishing business of the University of Cambridge.
- Posted by Ryan on November 18, 2016
- Posted by Mary Anne on November 16, 2016
Wellcome has launched an open research publishing platform which will enable their grantees to rapidly publish all outputs from their research. They use state-of-the-art services developed by and integrated with F1000Research which support faster research outputs, reproducibility and transparency - this includes integration with Overleaf for authoring services and editorial workflow. The platform will allow Wellcome grantees to publish a wide variety of outputs from standard research articles and data sets, through to null and negative results.